Podofilox

Product manufactured by Actavis Pharma, Inc.

Application Nr Approved Date Route Status External Links
NDA019795 None Topical None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Podofilox 0.5% Solution Is Indicated For The Topical Treatment Of External Genital Warts (Condyloma Acuminatum). This Product Is Not Indicated In The Treatment Of Perianal Or Mucous Membrane Warts (See Precautions ). Diagnosis Although Genital Warts Have A Characteristic Appearance, Histopathologic Confirmation Should Be Obtained If There Is Any Doubt Of The Diagnosis. Differentiating Warts From Squamous Cell Carcinoma (So-Called “bowenoid Papulosis”) Is Of Particular Concern. Squamous Cell Carcinoma May Also Be Associated With Human Papillomavirus But Should Not Be Treated With Podofilox 0.5% Solution.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Podofilox PODOFILOX ZINC3861806

Comments